 | | | | Merit Medical Systems Inc , a U.S. medical device manufacturer with a market value of $3.5 billion, is exploring options that include an outright sale to a private equity firm, people familiar with the matter said on Wednesday. | | | | | | Purdue Pharma on Wednesday is urging a bankruptcy judge to approve a $6 billion opioid settlement funded by its Sackler family owners, over objections from 20 states and the U.S. Department of Justice's bankruptcy watchdog. | | | | | | (Reuters) - A 57-year-old man with terminal heart disease who made history as the first person to receive a genetically modified pig's heart died on Tuesday afternoon at the University of Maryland Medical Center (UMMC), the hospital said. | | | | | | Ontario, Canada's most populous province, said on Wednesday it would end masking requirements for most indoor spaces later this month, and scrap virtually all COVID-19-related public health measures by end-April, citing the reduced threat of the pandemic. | | | | | | The Pan American Health Organization (PAHO) on Wednesday said COVID-19 cases fell by 26% across the Americas last week while deaths from the virus dropped by nearly 19%, but cautioned that some effective measures to curb infections should be maintained. | | | | | | The Czech Republic will drop most mask requirements, except for on public transport or in health or social care facilities, from March 14, as it winds down COVID-19 restrictions, Health Minister Vlastimil Valek said on Wednesday. | | | | | | A 57-year-old man with terminal heart disease who made history as the first person to receive a genetically modified pig's heart died on Tuesday afternoon at the University of Maryland Medical Center (UMMC), the hospital said. | | | | | | South Africa's Aspen Pharmacare will start supplying its branded COVID-19 vaccine to African nations by June, its chief executive told Reuters on Wednesday, after the drugmaker reported a 37% rise in profit for the half-year to Dec. 31. | | | | | | South African drugmaker Aspen Pharmacare on Wednesday reported a 37% rise in interim profit for the half year ending Dec. 31, as its branded medicines division benefited from rising demand during the successive waves of the coronavirus. | | | | | | Here's what you need to know about the coronavirus right now: | | | | | |
